X-32346044-G-C

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004006.3(DMD):ā€‹c.5485C>Gā€‹(p.Gln1829Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000186 in 1,206,720 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 74 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00023 ( 0 hom., 9 hem., cov: 22)
Exomes š‘“: 0.00018 ( 0 hom. 65 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

4
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 3.03
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065455437).
BP6
Variant X-32346044-G-C is Benign according to our data. Variant chrX-32346044-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 264026.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Benign=5, Uncertain_significance=1}. Variant chrX-32346044-G-C is described in Lovd as [Likely_benign]. Variant chrX-32346044-G-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000234 (26/111000) while in subpopulation EAS AF= 0.0062 (22/3548). AF 95% confidence interval is 0.0042. There are 0 homozygotes in gnomad4. There are 9 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 9 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DMDNM_004006.3 linkuse as main transcriptc.5485C>G p.Gln1829Glu missense_variant 39/79 ENST00000357033.9 NP_003997.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkuse as main transcriptc.5485C>G p.Gln1829Glu missense_variant 39/791 NM_004006.3 ENSP00000354923 P4

Frequencies

GnomAD3 genomes
AF:
0.000234
AC:
26
AN:
110952
Hom.:
0
Cov.:
22
AF XY:
0.000270
AC XY:
9
AN XY:
33286
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000967
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00618
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000189
Gnomad OTH
AF:
0.00134
GnomAD3 exomes
AF:
0.000718
AC:
131
AN:
182437
Hom.:
0
AF XY:
0.000609
AC XY:
41
AN XY:
67289
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000733
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00912
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000246
Gnomad OTH exome
AF:
0.000222
GnomAD4 exome
AF:
0.000182
AC:
199
AN:
1095720
Hom.:
0
Cov.:
30
AF XY:
0.000180
AC XY:
65
AN XY:
361746
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000285
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00549
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000357
Gnomad4 OTH exome
AF:
0.000653
GnomAD4 genome
AF:
0.000234
AC:
26
AN:
111000
Hom.:
0
Cov.:
22
AF XY:
0.000270
AC XY:
9
AN XY:
33344
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000966
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00620
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000189
Gnomad4 OTH
AF:
0.00132
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.000450
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000346
AC:
1
ExAC
AF:
0.000618
AC:
75
EpiCase
AF:
0.0000546
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 21, 2021Variant summary: DMD c.5485C>G (p.Gln1829Glu) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00072 in 182437 control chromosomes. The observed variant frequency is approximately 65 fold of the estimated maximal expected allele frequency for a pathogenic variant in DMD causing Dystrophinopathies phenotype (1.1e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.5485C>G in individuals affected with Dystrophinopathies and no experimental evidence demonstrating its impact on protein function have been reported. Ten clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (likely benign/benign, n=9; VUS, n=1). Based on the evidence outlined above, the variant was classified as benign. -
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 19, 2016- -
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 14, 2016p.Gln1829Glu in exon 39 of DMD: This variant is not expected to have clinical si gnificance because it has been identified in 0.8% (53/6508) of East Asian chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs754765424). -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJul 30, 2020- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 26, 2018- -
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 26, 2019This variant is associated with the following publications: (PMID: 18583217) -
Dilated cardiomyopathy 3B Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 28, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Aug 02, 2019- -
Long QT syndrome Benign:1
Benign, criteria provided, single submitterclinical testingCenter for Advanced Laboratory Medicine, UC San Diego Health, University of California San DiegoMay 26, 2018- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 05, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Duchenne muscular dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.27
.;T;.;.;T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.82
T;.;T;T;T
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.0065
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
0.96
N;N
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.1
.;N;.;N;N
REVEL
Benign
0.055
Sift
Benign
0.030
.;D;.;D;T
Sift4G
Benign
0.24
T;T;T;T;D
Polyphen
0.26
.;B;.;.;.
Vest4
0.17
MutPred
0.26
.;.;Loss of MoRF binding (P = 0.0534);Loss of MoRF binding (P = 0.0534);.;
MVP
0.50
MPC
0.016
ClinPred
0.037
T
GERP RS
5.8
gMVP
0.070

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs754765424; hg19: chrX-32364161; COSMIC: COSV63734814; API